- Home
- SBGI vs NVCR Comparison
SBGI vs NVCR Comparison
Compare SBGI & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBGI | NVCR |
|---|---|---|
| Founded | 1986 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SBGI | NVCR |
|---|---|---|
| Price | $16.44 | $13.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $21.00 | ★ $28.42 |
| AVG Volume (30 Days) | 455.0K | ★ 1.8M |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | ★ 6.07% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,337,000,000.00 | $642,269,000.00 |
| Revenue This Year | N/A | $9.75 |
| Revenue Next Year | $10.36 | $5.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.17 |
| 52 Week Low | $11.89 | $10.70 |
| 52 Week High | $18.36 | $34.13 |
Technical Indicators
Market Signals| Indicator | SBGI | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 59.92 | 60.37 |
| Support Level | $14.25 | $10.79 |
| Resistance Level | $17.21 | $13.94 |
| Average True Range (ATR) | 0.63 | 0.61 |
| MACD | 0.07 | 0.22 |
| Stochastic Oscillator | 74.29 | 80.48 |
Price Performance
Historical ComparisonAbout SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.